Skip to content

Effects of Garlic Supplements on Drug Metabolism

Garlic Metabolism and Cytochrome P450 Modulation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00122889
Enrollment
80
Registered
2005-07-22
Start date
2005-07-31
Completion date
2009-03-31
Last updated
2010-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Drug Interactions, Pharmacokinetics, Garlic, Complementary Therapies, Complementary and Alternative Medicine

Brief summary

This study will determine whether garlic supplements affect the way certain drugs are processed in the body.

Detailed description

Garlic supplements, which are often used to lower cholesterol and prevent cancer, are one of the most commonly used herbal products in the United States. However, little is known about the way garlic supplements may interact with prescription medications when used simultaneously. This study will investigate four commonly used garlic supplements: garlic powder with a low content of allicin (a compound with antibacterial properties), garlic powder with a high allicin content, garlic oil, and aged garlic. The effects of these 4 garlic products on the drug-metabolizing enzyme cytochrome P450 (CYP) and a drug transporter, P-glycoprotein (Pgp) will be examined. Participants will be randomly assigned to receive one of the four garlic supplements for 4 weeks. Drug probes of CYP and Pgp will be used to assess the in vivo activities of the substances. On the first day of garlic ingestion, blood collection will occur immediately after participants ingest their garlic supplement and 3, 4, and 6 hours after ingestion. Urine collection will occur immediately after participants' first garlic ingestion and 12, 15, and 72 hours after ingestion. Blood and urine collection will determine the concentration of the drug probes in the body, which will indicate changes in CYP and Pgp. Blood and urine tests will be repeated at the end of the study.

Interventions

DRUGAged garlic
DRUGGarlic powder with high allicin content
DRUGGarlic powder with low allicin content

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index (BMI) between 20 and 32 * Able to read and understand English * MUST LIVE WITHIN THE SEATTLE, WA AREA.

Exclusion criteria

* Current use of herbal medicines other than oral contraceptives * History of cardiopulmonary, liver, renal or endocrine disease * Allergy or sensitivity to any of the drugs that will be used in the probe cocktails or the garlic supplements * Daily consumption of vegetables with a high allium content, including garlic, shallots, leeks, and chives * Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Blood plasma and urine samples3 months

Secondary

MeasureTime frame
Blood plasma and breath samples.3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026